Leucovorin lacks evidence to use as autism treatment, FDA says
Stat News • 3/10/2026
Summary
The FDA has approved leucovorin for a rare brain disorder. However, the agency has retreated from earlier claims by top officials that it could benefit many children with autism, stating there is a lack of evidence for its use as an autism treatment.
Advertisement
Cluster Activity
2
1
2026-03-102026-03-11
Lindy Score Breakdown (V4.2)
1d
Age
3
Sources
from cluster
32
Hours Since Seen
Final Score28/100
CategoryBreaking
StatusActive
Recency Multiplier63% (0.5^32/48)
Hero EligibleYes
Story Timeline
- 2026-03-10Leucovorin lacks evidence to use as autism treatment, FDA says (current)
- 2026-03-11
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Emerging consensus: 3 sources
Age: 1 day(s) old - still early
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 3 sources
Breaking Similar stories
Opinion: The financial reason why parents beg me to diagnose their kids with autism
Stat News • 2 days ago
Amid dueling autism meetings, HHS cancels
Stat News • 1 day ago
STAT+: FDA approves leucovorin for rare disorder without trial data
Stat News • Today
STAT+: Pharmalot: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about a U.S. senator probing FDA, BioNTech founders leaving, and much more
Stat News • 1 day ago
STAT+: After UnitedHealth moved in, Oregon sought to rein in corporate health care. Now, it’s facing an early test
Stat News • 2 days ago
STAT+: As controversial decisions mount, FDA shuns public advisory meetings
Stat News • 2 days ago
STAT+: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again
Stat News • 1 day ago
STAT+: AI agents are rapidly spreading in health care, but validation is lacking
Stat News • Today
STAT+: Large drugmakers are developing fewer antibiotics, analysis finds
Stat News • 1 day ago